Literature DB >> 20722674

The impact of sickle cell trait on glycated haemoglobin in diabetes mellitus.

A J Bleyer1, S Vidya, L Sujata, G B Russell, D Akinnifesi, D Hire, Z Shihabi, M A Knovich, P Daeihagh, J Calles, B I Freedman.   

Abstract

AIMS: To determine the effect of sickle cell trait on measurement of glycated haemoglobin (HbA(1c)) in African American patients with diabetes mellitus.
METHODS: This is a retrospective study including 885 outpatients who underwent HbA(1c) testing. Medical record review and sickle cell trait determinations based on the HbA(1c) assay were performed in African American participants. The relationship between HbA(1c) and serum glucose measurements was analysed.
RESULTS: Data were obtained from 385 AA (109 with SCT, 22 with haemoglobin C trait and 254 without haemoglobinopathy) and 500 European American patients. In a model created through multivariate repeated-effects regression, the relationship between HbA(1c) and simultaneous serum glucose did not differ between African American subjects with and without the sickle cell trait, but differed between African American subjects without the sickle cell trait and European Americans (P = 0.0002).
CONCLUSIONS: Sickle cell trait does not impact the relationship between HbA(1c) and serum glucose concentration. In addition, it does not appear to account for ethnic difference in this relationship between African Americans and whites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722674     DOI: 10.1111/j.1464-5491.2010.03050.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2019-03-22

2.  Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention Program.

Authors:  Marie-France Hivert; Costas A Christophi; Kathleen A Jablonski; Sharon L Edelstein; Steven E Kahn; Sherita Hill Golden; Samuel Dagogo-Jack; Kieren J Mather; José A Luchsinger; A Enrique Caballero; Elizabeth Barrett-Connor; William C Knowler; Jose C Florez; William H Herman
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

Review 3.  Impact of Genetic Determinants of HbA1c on Type 2 Diabetes Risk and Diagnosis.

Authors:  Chloé Sarnowski; Marie-France Hivert
Journal:  Curr Diab Rep       Date:  2018-06-21       Impact factor: 4.810

4.  Limitations of hemoglobin A1c in the management of type 2 diabetes mellitus.

Authors:  Nemin Adam Zhu; Sonja Reichert; Stewart B Harris
Journal:  Can Fam Physician       Date:  2020-02       Impact factor: 3.275

5.  Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.

Authors:  Mary E Lacy; Gregory A Wellenius; Anne E Sumner; Adolfo Correa; Mercedes R Carnethon; Robert I Liem; James G Wilson; David B Sacks; David R Jacobs; April P Carson; Xi Luo; Annie Gjelsvik; Alexander P Reiner; Rakhi P Naik; Simin Liu; Solomon K Musani; Charles B Eaton; Wen-Chih Wu
Journal:  JAMA       Date:  2017-02-07       Impact factor: 157.335

Review 6.  Access to Hemoglobin A1c in Rural Africa: A Difficult Reality with Severe Consequences.

Authors:  Paul H Park; Sonak D Pastakia
Journal:  J Diabetes Res       Date:  2018-02-26       Impact factor: 4.011

7.  Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.

Authors:  Belinda Kweka; Eric Lyimo; Kidola Jeremiah; Suzanne Filteau; Andrea M Rehman; Henrik Friis; Alphaxard Manjurano; Daniel Faurholt-Jepsen; Rikke Krogh-Madsen; George PrayGod; Douglas C Heimburger
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

8.  HbA1c Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review.

Authors:  Lakshay Khosla; Sonali Bhat; Lee Ann Fullington; Margrethe F Horlyck-Romanovsky
Journal:  Prev Chronic Dis       Date:  2021-03-11       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.